Middle East and Africa Oxytocic Pharmaceuticals Market Size, Share, Growth, Trends and Industry Analysis: By Product Type, By Source, Synthetic Oxytocin), By End-User, and Country Forecast 2020-2031
Middle East And Africa Oxytocic Pharmaceuticals Market size was valued at US$ x million in 2024 and is expected to reach US$ x million by 2031, growing at a significant CAGR of x% from 2025-2031. Oxytocin is a female reproductive hormone secreted in the hypothalamus and released into blood circulation during childbirth to induce the labor and milk production in mothers. It is also used as uterotonic (induce uterine contractions) and reduce the hemorrhage after C-section.
Increase in the in the prevalence of post-partum hemorrhage due to lack of nutritious food supply to pregnant woman, rise in awareness about the pregnancy related conditions, escalation in complicated pregnancy cases, and rise in usage of oxytocin in maternity clinics are anticipated to boost the market over the forecast years. However, adverse effects associated with oxytocic drugs may restrain the growth of market over the forecast period.
This oxytocic pharmaceutical market report includes information on new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, and so on. For more information on the Data Bridge Market Research oxytocic pharmaceutical market, please contact us for an Analyst Brief; our team will assist you in making an informed market decision in order to achieve market growth.
Middle East and Africa oxytocic pharmaceuticals market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries oxytocic pharmaceuticals market is poised to grow at notable rate due to rise in awareness about oxytocin usage and expansion of businesses by the companies in Middle East region. South Africa oxytocic pharmaceuticals market accounted for significant share, which is attributed to increase in prevalence of post-partum hemorrhage, high usage of oxytocin, and rise in incidence of pre-mature labor cases.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Source |
|
|
By End User |
|
|
By Country |
|
Download Free Sample Report
2024 is the base year and 2031 is the forecast year of the Middle East and Africa oxytocic pharmaceuticals market.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Middle East And Africa Oxytocic Pharmaceuticals Market Introduction |
| 2.1.Middle East And Africa Oxytocic Pharmaceuticals Market - Taxonomy |
| 2.2.Middle East And Africa Oxytocic Pharmaceuticals Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Source |
| 2.2.3.End User |
| 2.2.4.Country |
| 3.Middle East And Africa Oxytocic Pharmaceuticals Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Middle East And Africa Oxytocic Pharmaceuticals Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Middle East And Africa Oxytocic Pharmaceuticals Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Intramuscular Injection |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Intravenous Injection |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Middle East And Africa Oxytocic Pharmaceuticals Market By Source, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Natural Oxytocin (Animal Pituitary Extracts) |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Synthetic Oxytocin |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Middle East And Africa Oxytocic Pharmaceuticals Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Maternity Clinics |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Middle East And Africa Oxytocic Pharmaceuticals Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. GCC Countries |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. South Africa |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Rest of MEA |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.GCC Countries Oxytocic Pharmaceuticals Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Intramuscular Injection |
| 9.1.2.Intravenous Injection |
| 9.2. Source Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Natural Oxytocin (Animal Pituitary Extracts) |
| 9.2.2.Synthetic Oxytocin |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Maternity Clinics |
| 9.3.2.Hospitals |
| 10.South Africa Oxytocic Pharmaceuticals Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Intramuscular Injection |
| 10.1.2.Intravenous Injection |
| 10.2. Source Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Natural Oxytocin (Animal Pituitary Extracts) |
| 10.2.2.Synthetic Oxytocin |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Maternity Clinics |
| 10.3.2.Hospitals |
| 11.Rest of MEA Oxytocic Pharmaceuticals Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Intramuscular Injection |
| 11.1.2.Intravenous Injection |
| 11.2. Source Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Natural Oxytocin (Animal Pituitary Extracts) |
| 11.2.2.Synthetic Oxytocin |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Maternity Clinics |
| 11.3.2.Hospitals |
| 12. Competition Landscape |
| 12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 12.2.1.Pfizer, Inc. |
| 12.2.2.Fresenius Kabi AG |
| 12.2.3.Novartis AG |
| 12.2.4.Cardinal Health |
| 12.2.5.Par Pharmaceutical, Inc. |
| 13. Research Methodology |
| 14. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
